The Scientific Advisory Board at Tvardi Therapeutics provides strategic guidance and expert insights to advance the company's clinical and preclinical programs. Comprised of distinguished scientists and industry leaders, the board collaborates closely with the R&D team to ensure scientific rigor and innovation in developing breakthrough medicines for cancer, chronic inflammatory diseases, and fibrotic diseases.